CSIMarket
 
Statera Biopharma Inc fka Cytocom Inc   (NASDAQ: STAB)
 

Statera Biopharma Inc Fka Cytocom Inc's Customers Performance

STAB



 
STAB's Source of Revenues During the corresponding time, Statera Biopharma Inc Fka Cytocom Inc recorded a revenue increase by 183.48 % year on year, sequentially revenue fell by -12.79 %. While revenue at the Statera Biopharma Inc Fka Cytocom Inc 's corporate clients

List of STAB Customers




for the same period Statera Biopharma Inc Fka Cytocom Inc recorded revenue increase by 183.48 % year on year, sequentially revenue fell by -12.79 %.

List of STAB Customers

Statera Biopharma Inc Fka Cytocom Inc's Business Units






Statera Biopharma Inc Fka Cytocom Inc's Comment on Sales, Marketing and Customers
















STAB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Statera Biopharma Inc fka Cytocom Inc 0.01 3.69 -102.54 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Statera Biopharma Inc fka Cytocom Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Statera Biopharma Inc fka Cytocom Inc’s corporate clients.
For your research, we’ve provided 9 tables on Statera Biopharma Inc fka Cytocom Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.